Informations générales (source: ClinicalTrials.gov)
Phase 3 Superiority Trial Evaluating the Benefit of Dematerialized Information Media for Patients With Advanced Sarcomas Receiving Systemic Treatment for Metastatic or Locally Advanced Disease.
Interventional
N/A
Centre Oscar Lambret (Voir sur ClinicalTrials)
mai 2024
avril 2030
02 mars 2026
ePPS-2202 is a study designed to evaluate the benefits of a dematerialised personalised
care plan (PCP) compared to standard information/PCP for patients with advanced sarcomas
receiving systemic treatment.
Participants will be randomised to an experimental group or a control group. Patients in
the experimental group will receive the dematerialised PCP in addition to the standard
PCP while patients in the control group will receive the standard PCP alone.
All patients will be followed until the end of second-line treatment, the start of a new
line of treatment, or until the 24-month follow-up.
Etablissements
| Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| CLCC INSTITUT GUSTAVE ROUSSY | Benjamin VERRET | 29/07/2026 13:00:18 | Contacter | ||
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Eugène Marquis - 35042 - Rennes 2983990 - Brittany Region 3030293 - France | Perrine VUAGNAT, MD | Contact (sur clinicalTrials) | |||
| Centre Léon Bérard - 69373 - Lyon 2996944 - Auvergne-Rhône-Alpes 11071625 - France | Armelle DUFRESNE, MD | Contact (sur clinicalTrials) | |||
| Centre Paul Strauss - 67033 - Strasbourg 2973783 - Grand Est 11071622 - France | Laura SOMME, MD | Contact (sur clinicalTrials) | |||
| CHU de Poitiers - 86021 - Poitiers 2986495 - Nouvelle-Aquitaine 11071620 - France | Marjorie HIRSCH, MD | Contact (sur clinicalTrials) | |||
| CHU Jean Minjoz - 25000 - Besançon 3033123 - Bourgogne-Franche-Comté 11071619 - France | Clément BOLOGNINI, MD | Contact (sur clinicalTrials) | |||
| Institut Claudius Regaud - 31059 - Toulouse 2972315 - Occitanie 11071623 - France | Contact (sur clinicalTrials) | ||||
| Institut de Cancérologie de l'Ouest - 44805 - Saint-Herblain 2979590 - Pays de la Loire Region 2988289 - France | Emmanuelle BOMPAS, MD | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Oscar Lambret - 59020 - Lille 2998324 - Hauts-de-France 11071624 - France | Diane PANNIER, MD | Contact (sur clinicalTrials) | |||
| Hôpital Pitié-Salpêtrière AP-HP - 75013 - Paris 2988507 - Île-de-France Region 3012874 - France | Aurore VOZY, MD | Contact (sur clinicalTrials) | |||
| Institut de Cancérologie de Lorraine - 54519 - Vandœuvre-lès-Nancy 2970797 - France | Sophie MARTIN, MD | Contact (sur clinicalTrials) | |||
Critères
Tous
- Sarcomas of soft tissues or viscera ;
- Inoperable metastatic or locally advanced disease ;
- Indication for systemic treatment with pazopanib, trabectedine, eribulin, ifosfamide
or dacarbazine monotherapy ;
- Patient covered by French social security ;
- Written, signed, informed consent ;
Exclusion Criteria:
- Prior inclusion in ePPS trial for a prior systemic treatment ;
- Poor understanding of French ;
- Difficulty accessing a computer ;
- Pregnant or nursing woman ;
- Person deprived of liberty or under guardianship ;
- Impossibility of undergoing medical follow-up for geographical, social or
psychological reasons.